ZHONG JI LS(00767.HK): Proposed Joint Establishment of RMB1 Billion Healthcare M&A Fund Focused on Longevity Science and Cell Industry
NewTimeSpace News: Zhong Ji Longevity Science Group Limited (00767.HK) announced on 7 July that its wholly-owned subsidiary Shenzhen Zhongji Health Science Co., Limited signed a memorandum of understanding with Shenzhen Zhongtou Huijin Fund Management Co., Ltd. to jointly set up a special M&A fund for the healthcare industry with a proposed size of RMB1 billion, to be raised in three tranches. The fund will target investments in longevity science, cell therapy, anti-ageing biomedicine and premium health management industries. The memorandum is non-binding and the cooperation is subject to further formalisation.
NewTimeSpace News: Zhong Ji Longevity Science Group Limited released a voluntary announcement dated 7 July 2026. Shenzhen Zhongji Health Science Co., Limited, the Company’s wholly-owned subsidiary, entered into a memorandum of understanding with Shenzhen Zhongtou Huijin Fund Management Co., Ltd. to jointly establish a dedicated M&A fund for the healthcare industry, with a target fund size of RMB1 billion to be raised in three phases: approximately RMB200 million for the first tranche, RMB300 million for the second tranche and RMB500 million for the third tranche.
The fund will focus on physical enterprises covering longevity science industry, cell industry, anti-ageing biomedicine and high-end health management sectors. Shenzhen Zhongtou Huijin will be responsible for coordinating fundraising, investment and fund management.
Shenzhen Zhongtou Huijin is a private fund manager registered with the Asset Management Association of China. It currently manages or co-manages funds worth about RMB10 billion, with a proposed contracted fund scale of around RMB120 billion. This memorandum serves only as a letter of intent and carries no legal binding force. The Company stated that the cooperation aligns with the Group’s development strategy for its longevity science business, which will further optimise its industrial layout and create new revenue streams.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags：
